NTLA

Intellia Therapeutics, Inc.NASDAQHealthcare

$13.13-1.06%ClosedMarket Cap: $1.55B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-04	Jones Trading	—	Buy	—
2026-03-03	Leerink Partners	—	Outperform	—
2026-03-03	RBC Capital	—	Sector Perform	—
2026-03-03	Canaccord Genuity	—	Buy	—
2026-03-03	Citizens	—	Market Outperform	—
2026-03-03	Wells Fargo	—	Equal Weight	—
2026-03-03	HC Wainwright & Co.	—	Buy	—
2026-03-02	Chardan Capital	—	Buy	—
2026-01-28	HC Wainwright & Co.	—	Buy	—
2025-11-12	Wolfe Research	—	Peer Perform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.00	$256.3M	16
Sun Dec 31	$-0.69	$668.0M	12
Mon Dec 31	$3.86	$1.57B	10
Tue Dec 31	$8.76	$2.47B	5